Journal
CHEMICAL COMMUNICATIONS
Volume 51, Issue 94, Pages 16832-16835Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5cc07022h
Keywords
-
Categories
Ask authors/readers for more resources
A new sensitiser (4) for use in photodynamic therapy (PDT) has been developed to enable control of ROS production as a function of pH. This pH dependent PDT behaviour was tested in HeLa cells and in SCID mice bearing human xenograft pancreatic cancer (BxPC-3) tumours.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
